Cite
HARVARD Citation
Sanchez-Garcia, J. et al. (n.d.). 114 FINAL RESULTS OF PHASE II RANDOMIZED TRIAL OF AZACITIDINE VERSUS SUPPORT TREATMENT IN PATIENTS WITH LOW RISK MYELODYSPLASTIC SYNDROME WITHOUT THE 5Q DELETION. Leukemia research. pp. S59-. [Online].